✦ LIBER ✦

A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee

✍ Scribed by Hellio le Graverand, M.-P.; Clemmer, R. S.; Redifer, P.; Brunell, R. M.; Hayes, C. W.; Brandt, K. D.; Abramson, S. B.; Manning, P. T.; Miller, C. G.; Vignon, E.

Book ID: 121837142
Publisher: BMJ Publishing Group
Year: 2012
Tongue: English
Weight: 352 KB
Volume: 72
Category: Article
ISSN: 0003-4967
DOI: 10.1136/annrheumdis-2012-202239

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 2-year randomized, double-blind, place

A 2-year randomized, double-blind, placebo-controlled, multicenter study of an oral selective iNOS inhibitor in subjects with symptomatic osteoarthritis of the knee

✍ M.-P. Hellio le Graverand-Gastineau; R. Clemmer; P. Redifer; R.M. Brunell; C.W. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Intra-articular hyaluronan is without cl

Intra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year

✍ Jorgensen, A.; Stengaard-Pedersen, K.; Simonsen, O.; Pfeiffer-Jensen, M.; Erikse 📂 Article 📅 2010 🏛 BMJ Publishing Group 🌐 English ⚖ 168 KB

Efficacy and safety of oral fumarate in

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

✍ Ludwig Kappos; Ralf Gold; David H Miller; David G MacManus; Eva Havrdova; Volker 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 209 KB

Evaluation of the Patient Acceptable Sym

Evaluation of the Patient Acceptable Symptom State in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis

✍ Maxime Dougados, Alan Moore, Shaohua Yu, Xavier Gitton 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 487 KB

First-dose analgesic effect of the cyclo

First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215]

✍ Ralf H Wittenberg, Ernest Schell, Gerhard Krehan… 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 251 KB

First-dose analgesic effect of the cyclo

✍ Ralf H Wittenberg, Ernest Schell, Gerhard Krehan… 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 251 KB